Age (< 50 yr. vs. ≥50 yr.)
|
1.535
|
0.688–3.422
|
0.295
|
–
|
–
|
–
|
Weight (< 60 kg vs. ≥60 kg)
|
0.720
|
0.408–1.270
|
0.295
|
–
|
–
|
–
|
Tumour size (< 4 cm vs. ≥4 cm)
|
1.322
|
0.745–2.347
|
0.340
|
–
|
–
|
–
|
Clinical Stage (I + II vs. III + IV)
|
1.409
|
1.028–1.930
|
0.033*
|
1.541
|
1.139–2.083
|
0.005*
|
Histologicala grade (WD vs. MD + PD)
|
3.659
|
1.641–8.162
|
0.002*
|
3.316
|
1.462–7.524
|
0.004*
|
Lymph Node (Neg. vs. Pos.)
|
3.427
|
1.812–6.483
|
< 0.0001*
|
2.769
|
1.453–5.277
|
0.002*
|
Menopause (Pre vs. Post)
|
2.184
|
0.979–.4.870
|
0.056
|
–
|
–
|
–
|
ERb (Neg. vs. Pos.)
|
0.843
|
0.476–1.491
|
0.557
|
–
|
–
|
–
|
PRc (Neg. vs. Pos.)
|
0.717
|
0.380–1.356
|
0.306
|
–
|
–
|
–
|
Her-2d (Neg. vs. Pos.)
|
1.784
|
0.999–3.184
|
0.050
|
–
|
–
|
–
|
TNBCe (No vs. Yes)
|
0.839
|
0.450–1.563
|
0.579
|
–
|
–
|
–
|
Methylation (Meth. vs. Unmeth.)
|
2.892
|
1.528–5.474
|
0.001*
|
2.286
|
1.190–4.389
|
0.013*
|